http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8647877-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_530e9260809e47473d400d1225d62c4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34287c3dc4c9dee17fa20b7a502d2499
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8635f6edaed63c86f651769f88cf1210
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ed4f00cf218e9c8dc089d18830f5149
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-101666
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-22
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-6428
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02
filingDate 2010-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a5fbd916102157a53395f52fd95420f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1404eea9e6deff9d330973194f02834
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d522711d5a03f2d0939642d7630b733c
publicationDate 2014-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-8647877-B2
titleOfInvention Preparation and use of nucleated red blood cell simulating particles and hematology control mixtures
abstract The present disclosure provides a nucleated red blood cell simulating particle, which may be leukocytes bound to a fluorescent-staining inhibitor capable of stably binding to the nucleus or a nucleic acid in a cell so as to reduce the binding capacity of the particles to a fluorescent dye during their detection. The present disclosure also provides a method for preparing nucleated red blood cell simulating particles, including the following steps: (a) obtaining purified leukocytes; (b) suspending the leukocytes in a cell treatment solution containing a fluorescent-staining inhibitor which stably binds to the nucleus or a nucleic acid in a cell, and (c) washing the obtained product. The present disclosure also provides a hematology control mixture containing the nucleated red blood cell simulating particles. In addition, the present disclosure describes the use of the nucleated red blood cell simulating particles and the hematology control mixtures comprising the same, for the quality control of a blood cell analyzer.
priorityDate 2009-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7285417-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6403377-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6962817-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7354767-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7754487-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6406915-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6221668-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003009857-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7195919-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6653137-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7176031-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007072298-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6187590-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0709458-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5858790-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5512485-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6200500-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6399388-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010143955-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7135341-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6911313-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7198953-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0042969-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5250437-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6723563-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411210
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID457193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57272424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129888650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226493848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129205934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386

Total number of triples: 70.